Product Information
TIMOLOL MALEATE 0.5% EYE DROP is a generic product labeled by Nordic Pharma, Inc., priced at $1.2555 per EA under NDC 69918060160. Its NADAC has been published 219 times since Jul 27, 2022.
FDA first approved this application on Dec 13, 2021. Its Orange Book therapeutic-equivalence code is AT3.
Strength
5 mg/mL
Manufacturer
Nordic Pharma, Inc.NDC
69918060160
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA212592FDA Approved
12/13/2021
TE Code
AT3
On Market Since
2/26/2022
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROP has been published 219 times since Jul 27, 2022, and over the history we have for it it has declined 74.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2555 per EA |
|---|---|
| All-time high | $4.8674 (Aug 10, 2022) |
| All-time low | $1.1871 (Aug 19, 2026) |
| 52-week high | $2.2892 |
| 52-week low | $1.1871 |
| Median price | $2.4364 |
| Average price | $2.6310 |
| Largest weekly change | -49.1% (Jan 17, 2024) |
| Weeks tracked | 219 |
| Tracking since | Jul 27, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Timolol Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nordic Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROP, manufactured by Nordic Pharma, Inc., is $1.2555 per EA (NDC 69918060160), effective Sep 30, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has declined 74.2%. It has been tracked across 219 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROP?
Since Jul 27, 2022, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has ranged from a low of $1.1871 (Aug 19, 2026) to a high of $4.8674 (Aug 10, 2022), with a median of $2.4364 per EA.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of TIMOLOL MALEATE 0.5% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROP?
TIMOLOL MALEATE 0.5% EYE DROP (NDC 69918060160) is labeled by Nordic Pharma, Inc., and CMS classifies it as a generic product.